A carregar...

Erythropoietin: still on the neuroprotection road

Acute stroke is one of the major causes of death and disabilities. Since the 1980s many clinical studies have been conducted to evaluate neuroprotective approaches to treat this important brain vascular event. However, to date the only drug approved (recombinant tissue plasminogen activator [rtPA])...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Subirós, Nelvys, del Barco, Diana García, Coro-Antich, Rosa M.
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3349080/
https://ncbi.nlm.nih.gov/pubmed/22590480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285611434926
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!